1. Home
  2. IRD vs ORKT Comparison

IRD vs ORKT Comparison

Compare IRD & ORKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRD
  • ORKT
  • Stock Information
  • Founded
  • IRD 2018
  • ORKT 2003
  • Country
  • IRD United States
  • ORKT Singapore
  • Employees
  • IRD N/A
  • ORKT N/A
  • Industry
  • IRD
  • ORKT
  • Sector
  • IRD
  • ORKT
  • Exchange
  • IRD NYSE
  • ORKT NYSE
  • Market Cap
  • IRD 36.0M
  • ORKT 34.7M
  • IPO Year
  • IRD N/A
  • ORKT 2024
  • Fundamental
  • Price
  • IRD $1.13
  • ORKT $1.23
  • Analyst Decision
  • IRD Strong Buy
  • ORKT Strong Buy
  • Analyst Count
  • IRD 1
  • ORKT 1
  • Target Price
  • IRD $8.00
  • ORKT $5.00
  • AVG Volume (30 Days)
  • IRD 150.5K
  • ORKT 6.9M
  • Earning Date
  • IRD 02-24-2025
  • ORKT 10-16-2024
  • Dividend Yield
  • IRD N/A
  • ORKT N/A
  • EPS Growth
  • IRD N/A
  • ORKT N/A
  • EPS
  • IRD N/A
  • ORKT N/A
  • Revenue
  • IRD $8,381,000.00
  • ORKT $3,904,592.00
  • Revenue This Year
  • IRD N/A
  • ORKT N/A
  • Revenue Next Year
  • IRD $29.37
  • ORKT N/A
  • P/E Ratio
  • IRD N/A
  • ORKT N/A
  • Revenue Growth
  • IRD N/A
  • ORKT N/A
  • 52 Week Low
  • IRD $0.81
  • ORKT $0.62
  • 52 Week High
  • IRD $2.71
  • ORKT $8.00
  • Technical
  • Relative Strength Index (RSI)
  • IRD N/A
  • ORKT N/A
  • Support Level
  • IRD N/A
  • ORKT N/A
  • Resistance Level
  • IRD N/A
  • ORKT N/A
  • Average True Range (ATR)
  • IRD 0.00
  • ORKT 0.00
  • MACD
  • IRD 0.00
  • ORKT 0.00
  • Stochastic Oscillator
  • IRD 0.00
  • ORKT 0.00

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

About ORKT ORANGEKLOUD TECHNOLOGY INC

Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.

Share on Social Networks: